Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples